A pivotal role in escaping lymphocyte-mediated eradication is also represented by PD-1 signaling: the tumor microenvironment, through the action of type II interferons, cause the overexpression of PD-L1 by the cancer cells, contributing to a decrease in the ability of inducing tumor cell death. Here, CD274 is linked to cancer.